Vascular CREB levels are decreased in in vivo models of hypertension, atherosclerosis and insulin resistance27, and targeted cardiac expression of dominant-negative CREB augments oxidative stress, mitochondrial dysfunction and mortality in vivo28. The gene discussed is CREB1; the disease is atherosclerosis.